Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Silvia Cohn

Datos Biográficos

ID9067352
NOMBRESilvia Cohn
NOMBRESSilvia
APELLIDOCohn
FIRMACOHN S
AFILIACIONESJohns Hopkins University
VERIFICADONo
TOTAL DE OBRAS2
TOTAL DE CITAS0
TOTAL COMO AUTOR2
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2023
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0
  • Cost and cost-effectiveness of pediatric home-based versus facility-based TB Preventive Treatment in Ethiopia (CHIP-TB)

    Open Access•Akash Malhotra, Ahmed Bedru et al.•ARTICLE•PLOS Global Public Health•2025

    Tuberculosis preventive treatment (TPT) is an essential intervention recommended for all child contacts in Ethiopia under 15 years who are at risk of tuberculosis (TB) infection. We conducted a cost and cost-effectiveness analysis of home-based versus facility-based TPT provision for child contacts in Ethiopia. As part of the CHIP TB trial, a pragmatic, cluster-randomized trial conducted at eighteen clinics in Ethiopia, clinics were randomized to…

  • Contextualizing and optimizing novel strategies to improve the latent TB continuum of care

    Open Access•Isadora Salles, Paula Travassos et al.•ARTICLE•PLOS Global Public Health•2023

    Tuberculosis (TB) causes 1 in 3 deaths among people living with HIV (PLHIV). Diagnosing and treating latent tuberculosis infection (LTBI) is critical to reducing TB incidence and mortality. Blood-based screening tests (e.g., QuantiFERON-TB Gold Plus (QFT+)) and shorter-course TB preventive therapy (TPT) regimens such as 3HP (3 months weekly isoniazid-rifapentine) hold significant promise to improve TB outcomes. We qualitatively explored barriers …

Sin obras prominentes en esta página.

  • Contextualizing and optimizing novel strategies to improve the latent TB continuum of care

    Open Access•Isadora Salles, Paula Travassos et al.•ARTICLE•PLOS Global Public Health•2023

    Tuberculosis (TB) causes 1 in 3 deaths among people living with HIV (PLHIV). Diagnosing and treating latent tuberculosis infection (LTBI) is critical to reducing TB incidence and mortality. Blood-based screening tests (e.g., QuantiFERON-TB Gold Plus (QFT+)) and shorter-course TB preventive therapy (TPT) regimens such as 3HP (3 months weekly isoniazid-rifapentine) hold significant promise to improve TB outcomes. We qualitatively explored barriers …

  • Cost and cost-effectiveness of pediatric home-based versus facility-based TB Preventive Treatment in Ethiopia (CHIP-TB)

    Open Access•Akash Malhotra, Ahmed Bedru et al.•ARTICLE•PLOS Global Public Health•2025

    Tuberculosis preventive treatment (TPT) is an essential intervention recommended for all child contacts in Ethiopia under 15 years who are at risk of tuberculosis (TB) infection. We conducted a cost and cost-effectiveness analysis of home-based versus facility-based TPT provision for child contacts in Ethiopia. As part of the CHIP TB trial, a pragmatic, cluster-randomized trial conducted at eighteen clinics in Ethiopia, clinics were randomized to…

Medicine (2 obras) · Tuberculosis Research and Epidemiology (2 obras) · Business (1 obras) · Child Nutrition and Water Access (1 obras) · Cost effectiveness (1 obras) · Cost–benefit analysis (1 obras) · Environmental health (1 obras) · Family medicine (1 obras) · Global Maternal and Child Health (1 obras) · Health care (1 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae